Advanced search×

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy.

Norbert Pfeiffer, Maria-Luise Scherzer, Hubert Maier, Sonja Schoelzel, Mark C Jasek, Jeanette A Stewart, and William C Stewart

Clin Ophthalmol (2010) PMID 20505839

To assess the safety and efficacy of changing to the travoprost/timolol fixed combination (TTFC) from other mono- or adjunctive therapies.

Version: za2963e q8za9 q8zb7 q8zc9 q8zd7 q8zee q8zf8 q8zga
View PDF

Similar articles you may find interesting…

  1. Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.
    Norbert Pfeiffer and Norbert Pfeiffer and

    Graefes Arch Clin Exp Ophthalmol 249(7):1065-71 (2011) PMID 21499770

    Two hundred and fifty-three patients underwent the 4-week run-in period. Switching to travoprost resulted in adequate IOP control (<19 mmHg) for 21.7% of patients. After 3 months of treatment, both drug combinations statistically significantly reduced the mean IOP at each time point (8:00, 12:00 a...
    Buy PDF
  2. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanopro...
    Françoise F Brignole-Baudouin, Luisa L Riancho, ... Christophe C Baudouin

    J Ocul Pharmacol Ther 27(3):273-80 (2011) PMID 21410334

    The NR and AB assays demonstrated that cells incubated with travoprost/timolol PQ had significantly better viability than cells incubated with latanoprost/timolol BAK, travoprost/timolol BAK, BAK 0.015%, and BAK 0.020% (P<0.0001 for all). As assessed with YO-PRO-1 and Hoechst 33342 relative to cell...
    Buy PDF
  3. Estimating the long-term visual field consequences of average daily intraocular pressure and variance : a clinical trial comparing timolol, ...
    J P JP Nordmann, C C Lepen, ... G G Berdeaux

    Clin Drug Investig 23(7):431-8 (2003) PMID 17535054

    Better control of daily IOP average and variance should avoid new VFDs. Prostaglandins controlled the variance better than timolol, and travoprost was found to be the drug having the most effect on IOP average. Longitudinal prospective data collection should be performed to confirm these findings....
    Buy PDF